Tristel (TSTL) - Total Liabilities

Latest as of December 2025: GBX11.88 Million GBX ≈ $1.45K USD

Based on the latest financial reports, Tristel (TSTL) has total liabilities worth GBX11.88 Million GBX (≈ $1.45K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Tristel - Total Liabilities Trend (2003–2025)

This chart illustrates how Tristel's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Tristel to evaluate short-term liquidity relative to the company's equity base.

Tristel Competitors by Total Liabilities

The table below lists competitors of Tristel ranked by their total liabilities.

Company Country Total Liabilities
TECH INVEST GROUP ZY-02
F:6N2
Germany €8.89 Million
Yowie Group Ltd
AU:YOW
Australia AU$7.29 Million
Impax Environmental Markets PLC
LSE:IEM
UK GBX90.37 Million
Nexity Global SA
WAR:NXG
Poland zł1.54 Million
District Copper Corp
V:DCOP
Canada CA$91.77K
Star Pacific Tbk
JK:LPLI
Indonesia Rp5.88 Billion
Capella Minerals Ltd
V:CMIL
Canada CA$1.84 Million
GOLCAP RESOURCES CORP
F:2SO0
Germany €1.84 Million

Liability Composition Analysis (2003–2025)

This chart breaks down Tristel's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TSTL market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.35 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tristel's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tristel (2003–2025)

The table below shows the annual total liabilities of Tristel from 2003 to 2025.

Year Total Liabilities Change
2025-06-30 GBX12.34 Million
≈ $1.50K
+5.50%
2024-06-30 GBX11.70 Million
≈ $1.42K
+9.51%
2023-06-30 GBX10.68 Million
≈ $1.30K
+9.54%
2022-06-30 GBX9.75 Million
≈ $1.19K
-0.96%
2021-06-30 GBX9.85 Million
≈ $1.20K
-21.03%
2020-06-30 GBX12.47 Million
≈ $1.52K
+142.91%
2019-06-30 GBX5.13 Million
≈ $624.66
+24.82%
2018-06-30 GBX4.11 Million
≈ $500.43
+1.56%
2017-06-30 GBX4.05 Million
≈ $492.77
+5.91%
2016-06-30 GBX3.82 Million
≈ $465.27
+34.27%
2015-06-30 GBX2.85 Million
≈ $346.52
-5.22%
2014-06-30 GBX3.00 Million
≈ $365.62
+60.61%
2013-06-30 GBX1.87 Million
≈ $227.65
-19.70%
2012-06-30 GBX2.33 Million
≈ $283.49
+16.79%
2011-06-30 GBX2.00 Million
≈ $242.73
-42.19%
2010-06-30 GBX3.45 Million
≈ $419.89
+97.43%
2009-06-30 GBX1.75 Million
≈ $212.68
+21.39%
2008-06-30 GBX1.44 Million
≈ $175.21
-29.62%
2007-06-30 GBX2.05 Million
≈ $248.94
+46.14%
2006-06-30 GBX1.40 Million
≈ $170.34
+15.61%
2005-06-30 GBX1.21 Million
≈ $147.34
+18.03%
2004-04-30 GBX1.03 Million
≈ $124.83
0.00%
2003-06-30 GBX1.03 Million
≈ $124.83
--

About Tristel

LSE:TSTL UK Medical Instruments & Supplies
Market Cap
$2.26 Million
GBX18.60 Billion GBX
Market Cap Rank
#29838 Global
#662 in UK
Share Price
GBX387.50
Change (1 day)
+0.00%
52-Week Range
GBX352.00 - GBX440.00
All Time High
GBX617.87
About

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more